Global Medical Isotopes Market Size To Exceed USD 14.90 Billion By 2035 | CAGR of 8.65%
Category: HealthcareGlobal Medical Isotopes Market Size To Exceed USD 14.90 Billion By 2035
According to a research report published by Spherical Insights & Consulting, the Global Medical Isotopes Market is Expected to Grow from USD 5.98 Billion in 2024 to USD 14.90 Billion by 2035, at a CAGR of 8.65% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 250 pages with 150 Market data tables and figures & charts from the report on the " Global Medical Isotopes Market Size, Share, and COVID-19 Impact Analysis, By Type (Stable Isotopes, and Radioisotopes), By Application (Diagnostic, and Nuclear Therapy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." https://www.sphericalinsights.com/reports/medical-isotopes-market
The market for medical isotopes includes the production, distribution, and application of radioactive and stable isotopes for nuclear therapy, diagnostic imaging, and medical research. Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and targeted radionuclide treatments all depend on these isotopes. Increases in the incidence of chronic illnesses, the effectiveness of alpha radioimmunotherapy in treating some types of cancer, and advancements in nuclear imaging technology are the main factors driving the medical isotopes market growth. The market for medical isotopes is primarily driven by rising patient knowledge about radiation and radiation therapy. Ongoing advancements in nuclear medicine, including the development of innovative radiopharmaceuticals and imaging techniques, are driving the need for a variety of medical isotopes. Initiatives to increase access to radiation therapy, such as expanding hospital facilities or deploying mobile units, are more likely to succeed when patients are aware of their availability and advantages. However, the market for medical isotopes is constrained by factors such as restricted raw material availability, short half-lives, high production costs, and regulatory obstacles.
The radioisotopes segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the type, the medical isotopes market is divided into stable isotopes and radioisotopes. Among these, the radioisotopes segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Improvements in reactor and cyclotron technology have increased the availability and efficiency of producing a range of radioisotopes, guaranteeing a consistent supply to satisfy growing demand.
The diagnostic segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the medical isotopes market is divided into diagnostic and nuclear therapy. Among these, the diagnostic segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Numerous governments around the world have recognized the importance of nuclear medicine and have provided funding and support for research and development initiatives that have improved the accessibility and use of diagnostic isotopes.
North America is expected to hold the majority share of the global medical isotopes market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global medical isotopes market during the forecast period. The region's competitiveness in the market for medical isotopes is increased by these partnerships, which usually result in significant infrastructure investments, such as new production plants and research laboratories.
Asia Pacific is anticipated to grow at the fastest pace in the global medical isotopes market during the forecast period. Government initiatives and supportive legislation play a major role in the growth of the medical isotopes market in this region. Faster regulatory approvals for medical isotopes used in diagnosis and treatment help the market grow.
Major vendors in the global medical isotopes market are GE Healthcare, Nordion Inc., Curium, Mallinckrodt Pharmaceuticals, Jubilant Radiopharma, IBA Radiopharma Solutions, Eczacibasi-Monrol Nuclear Products, Northstar medical radioisotopes, LLC, Canadian Nuclear Laboratories (CNL), Isotopen Technologien München (ITM), and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In January 2025, YAP Therapeutics, Inc. and NorthStar Medical Radioisotopes, LLC partnered to research and manufacture radiopharmaceuticals for the treatment of cancer and other chronic illnesses.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the medical isotopes market based on the below-mentioned segments:
Global Medical Isotopes Market, By Type
- Stable Isotopes
- Radioisotopes
Global Medical Isotopes Market, By Application
- Diagnostic
- Nuclear Therapy
Global Medical Isotopes Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?